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ABSTRACT
Cholecystokinin (CCK) affects the intestinal motility but the character of hormone-evoked alterations 
is not clear. The aim of this study was to examine precisely the effects of CCK-octapeptide (CCK-OP) on 
duodenal myoelectric activity in non-fasted sheep in the course of chronic experiments. In fi ve rams the bipolar 
platinum electrodes were surgically attached to the wall of the duodenal bulb, the distal duodenum and jejunum. 
Strain gauge force transducer was mounted near the duodenal electrode to verify the myoelectric recordings. 
During continuous myoelectrical recordings, 0.15 M NaCl or CCK-OP was administered intravenously. Slow 
injections of CCK-OP at the doses of 20 (over 30 s), 200 (over 30 or 60 s), and 2000 (over 30, 60, or 120 s) 
ng/kg of body weight were each administered in the course of duodenal phase 1, 2a, or 2b of the migrating 
motor complex (MMC), i. e. 5 min after the onset of each phase. Injections of the smallest dose of CCK-OP 
exerted a slight and mostly not signifi cant effect on the duodenal bulb and the duodenal myoelectric activity 
index (MAI) values. In the duodenal bulb, the effects of CCK-OP on myoelectric activity were dose-dependent 
and closely related to the phase of the MMC. In the duodenum, the higher doses of the hormone evoked short 
stimulatory followed by longer inhibitory biphasic effects on MAI. These effects were inversely related to the 
duration of hormone injection. Infusions of hormone at the higher doses caused less pronounced biphasic effect. 
It is concluded that CCK evokes stimulatory and inhibitory (biphasic) physiological effect on duodenal motility 
in non-fasted sheep. 
Key words: sheep, duodenal bulb, duodenum, myoelectric and motor activity, cholecystokinin octapeptide, 
migrating myoelectric complex 
Introduction
Duodenal motility is a basic function for normal digestion and absorption, and is 
controlled by complex neurohormonal mechanisms. Cholecystokinin (CCK) is one of 
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the main gastrointestinal hormones involved in this control (OUYANG and COHEN, 1981). 
The regulatory role of the hormone is relatively broad thus it also contributes in the 
control of other physiological functions (LIDDLE, 1994). The recognized effect of CCK 
on small-intestinal motility is evident. The hormone, usually applied as CCK-octapeptide 
(CCK-OP) as the natural CCK form present in sheep (TITCHEN, 1984) inhibits the arrival 
of the migrating motor or myoelectric complex (MMC) and induces a fed-like pattern 
in the upper small bowel (HEPPELL et al., 1982; MĄCZKA et al., 1993). CCK thus rather 
stimulates the duodenal digestive motility. It evokes the specifi c spike burst pattern 
(NIEDERAU and KARAUS, 1991; SNINSKY et al., 1984) and may increase spiking activity 
in vivo and in vitro (MERLE et al., 2000; NGU, 1985; XU et al., 1998). However, opposite 
and dual effects of CCK-OP and its amphibian analogue, cerulein, have been reported 
(GIULIANI et al., 1990; MARTINS et al., 2006). In sheep, CCK peptides also inhibit the 
arrival of the MMC in the upper small intestine (ROMAŃSKI, 2007), but their effect on 
intestinal motility has not been fully elucidated so far in spite of several studies performed 
(BUENO and PRADDAUDE, 1979; ONAGA et al., 1997; ROMAŃSKI, 2004). Thus in sheep, 
the dual effect of CCK upon the small-intestinal motility can also be expected. It still 
remains poorly elucidated what is the character of duodenal spiking activity response 
to CCK (stimulatory or inhibitory), and what is the difference in this response between 
duodenal bulb and duodenum in relation to the various MMC phases in sheep. 
Materials and methods
Animal preparation. Five healthy adult rams of the Polish Merino breed weighing 38-
43 kg each were used. The rams were fed with good quality hay, 1 kg daily, and with grain 
mixture (Dolpasz, Wrocław), then fasted for 24 h before surgery but freely allowed the 
drinking water. After general and local anesthesia, right lateral laparotomy was performed 
and two bipolar platinum electrodes were implanted at the serosal side to the duodenal 
bulb, 5. 5-6 cm distally to the pyloric ring and to the distal duodenum, 50 cm below the 
bulbar electrode. Additional two electrodes were placed in the jejunum, 200 and 300 cm 
from the duodenal electrode to confi rm the presence of the MMC cycles. A strain gauge 
force transducer (RB Products, Madison), calibrated individually before the surgery, was 
attached just near the duodenal electrode to verify the myoelectric activity tracings. Other 
details of this procedure have been described elsewhere (ROMAŃSKI, 2004; ROMAŃSKI, 
2007). Marked wires were exteriorized through the stab incision, soldered to the plug and 
fi xed to the wool. Within two-three days the animals returned to normal feeding. The skin 
sutures were removed 10 days after the surgery. 
Experimental procedure. A total of 110 experiments lasting 5-6 h each were conducted. 
Myoelectric and motor activities were continuously recorded using a multichannel 
electroencephalograph (Reega Duplex TR XVI, Alvar Electronics, Montreuil) also 
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adapted for mechanical activity recordings. Twenty four hours before each experiment, 
food was removed from the cage. At least two consecutive phases 3 of the MMC including 
one full normal cycle of the MMC were recorded each time. During control recordings, 
injections of 5 mL 0.15 M NaCl were performed over 30 s into the jugular vein through 
a thin polyethylene catheter introduced before the experiment. Infusions of saline at a 
rate of 1 mL/min for 60 min were also performed. The saline injections were performed 
during the course of phases 1 (5 min after its start in the duodenum), 2a (5 min after its 
start in the duodenum), or phase 2b (5 min after its start in the duodenum) of the MMC. 
The saline infusions were started 5 min after the origin of duodenal phase 2b of the 
MMC. In the group of appropriate experiments, slow intravenous injections of CCK-OP 
(Sincalide, Squibb Institute, Princeton) at the smallest, moderate, and highest doses, i. e. 
20, 200, or 2000 ng/kg were applied. The smallest dose of CCK peptide was administered 
over 30 s, the moderate dose over 30 or 60 s, and the highest dose over 30, 60, or 120 
s. Each dose was given in separate randomized experiments at the same periods as the 
saline injections. After saline or CCK peptide administration, the myoelectric and motor 
activities were recorded until the arrival of the fi rst organized phase 3 of the MMC. After 
cessation of all the experiments, the animals were sacrifi ced and the positions of the 
electrodes and the strain gauge force transducer were confi rmed during autopsy. 
Data analysis. The MMC cycles and their phases were identifi ed in the duodenum 
and jejunum according to the criteria proposed by CODE and MARLETT (1975) with a 
slight modifi cation (ROMAŃSKI, 2002). The division of phase 2 into phases 2a and 2b 
of the MMC, proposed earlier by DENT et al. (1983) was performed according to more 
precise criteria (ROMAŃSKI, 2007). The myoelectric and motor recordings of duodeno-
jejunal myoelectric activity were visually analysed and the myoelectric activity index 
(MAI) values were calculated (ROMAŃSKI, 2004). The MAI values were calculated by 
multiplying the average amplitude of each spike burst within the period examined, as 
described previously (ROMAŃSKI, 2006), by the duration of this spike burst and expressed 
as the sum of the areas of all the spike bursts during one minute (μV · s · min-1). Spike 
bursts with amplitudes below 2-3 μV were omitted. The duration of the periods was equal 
to one minute. In the recordings obtained from the experiments with saline and CCK 
peptide injections, the MAI values were calculated in four one-minute periods, i. e. before 
the injection and ten one-minute periods after the CCK-OP injection. On the tracings, the 
measurements were performed using a caliper with an accuracy of about 0.2-0.3 mm. 
Statistical elaboration of data. All the values were grouped and the means and 
standard deviations were calculated. Statistical signifi cances, i. e. when P<0.05, P<0.01 
or P<0.001 were calculated using the Student’s t-test for paired and unpaired values, 
where appropriate, preceded by one-way analysis of variance (SNEDECOR and COCHRAN, 
1971). 
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Results
 Injections of saline evoked no effect and these data were not shown here. The results 
obtained from the motor recordings were relevant to the myoelectric correlates and also 
were not included to the presented results. 
Table 1. Duration of the stimulatory and inhibitory effects of the injections of CCK-OP given 
during phase 1 of the MMC on the myoelectric activity index (MAI) of the duodenum in non-
fasted sheep
0 1 2 3 4 5 6 7 8 9 10












































































































































Explanations: values expressed in μV · s · min-1, period 0 - control, i.e. the last minute before injection of CCK 
peptide. The values of three previous control periods, insignifi cantly different from period 0, are not shown. 
Periods 1-10 - consecutive one-minute periods after CCK peptide administration. Means (bold numbers) ± S. 
D. a P<0.05; b P<0.01; c P<0.001. Statistical signifi cances vs. the relevant value of period 0. Student’s t-test for 
paired values preceded by ANOVA I. 
In the myoelectrical recordings, slow injections of CCK-OP at the smallest dose 
during phase 1 of the MMC (over 30 s) evoked a transient but signifi cant excitatory 
effect in the duodenum over the fi rst minute after cessation of the peptide injection, 
lasting 5-15 s (Table 1). When CCK peptide was injected at the moderate dose during 
phase 1 of the MMC over 30 or 60 s, the stimulatory effect was greater. Furthermore, 
the MAI values slightly and not signifi cantly increased within the last two minutes of 
observation. Administration of the peptide at the highest dose in the course of phase 1 of 
the MMC over 30 s induced signifi cant and sustained excitatory response. The greatest 
MAI values were obtained during the fi rst minute following CCK administration. During 
next two minutes the values were greater than in control and not signifi cantly different 
from control while during the remaining minutes the MAI values increased exceeding the 
border of signifi cance (Table 1). When CCK-OP was given at the highest dose during 60 
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s, the effect was similar but not signifi cantly different values were observed during 2-5 
minutes following hormone administration. The application of the highest dose of CCK-
OP over 120 s produced similar effect as that after CCK administration over 60 s while 
the not signifi cantly different but elevated MAI values were obtained within 2-6 and during 
eight minute following CCK peptide application (Table 1). 
Table 2. Duration of the stimulatory and inhibitory effects of the injections of CCK-OP given 
during phase 2a of the MMC on the myoelectric activity index (MAI) of the duodenum in non-
fasted sheep
0 1 2 3 4 5 6 7 8 9 10
































































































































Explanation as in Table 1
When CCK-OP was given in the course of phase 2a of the MMC at the smallest dose 
(over 30 s) the excitatory response, observed within the fi rst minute was slight and not 
signifi cant (Table 2). Administration of a moderate dose of CCK peptides during phase 
2a of the MMC induced the signifi cant stimulatory effect within the fi rst minute when 
the peptides were given within 30 s while during the second and last four minutes the 
values were higher although did not reach the statistical signifi cance threshold. When the 
peptide was introduced at the moderate dose within 60 s during phase 2a of the MMC, 
after the statistically signifi cant excitatory period lasting fi rst three minutes following 
peptide administration the values returned to the control level. Administration of CCK-
OP at the highest dose was the most effective since the increase in MAI values within the 
fi rst minute was the highest regardless of the duration of injection (Table 2). Following 
injection of the high dose of CCK-OP in the course of phase 2a of the MMC over 30, 
K. W. Romański: Effects of cholecystokinin octapeptide on myoelectric activity of ovine duodenum
348
K. W. Romański: Effects of cholecystokinin octapeptide on myoelectric activity of ovine duodenum
Vet. arhiv 80 (3), 343-353, 2010
after signifi cant increase in the duodenal MAI values were elevated during the next two 
minutes while the signifi cantly different was the value obtained during the fourth minute. 
Then during next two minutes the transient, not signifi cant inhibition was observed. When 
the hormone was given over 60 s the results were similar but the signifi cant excitatory 
period lasted fi rst four minutes following hormone administration. 
When CCK-OP was given during phase 2a of the MMC over 120 s the signifi cant 
stimulatory effect arrived within fi rst two minutes, not signifi cant increase in MAI was 
seen during the third minute and signifi cant inhibitory response was observed in the 
course of the next two minutes. The remaining values were not much different from the 
control (Table 2). 
Table 3. Duration of the stimulatory and inhibitory effects of the injections of CCK-OP given 
during phase 2b of the MMC on the myoelectric activity index (MAI) of the duodenum in non-
fasted sheep
0 1 2 3 4 5 6 7 8 9 10


































































































































Explanation as in Table 1
Injection of CCK-OP at the smallest dose in the course of phase 2b of the MMC (over 
30 s), induced slight and not signifi cant elevation of MAI values within the fi rst minute 
following hormone administration and during the second minute the effect was reversed. 
The remaining values were close to those during the control period (Table 3). Injection 
the moderate dose of CCK in the course of phase 2b of the MMC over 30 s evoked 
signifi cant increase of MAI values within the fi rst minute following hormone application 
while during the next six minutes the effect was inhibitory and statistically signifi cant. 
Administration of CCK at the moderate dose over 60 s produced roughly similar but little 
more attenuated response. The elevation of MAI values during the fi rst minute following 
peptide injection was slight and not signifi cant and statistically signifi cant inhibitory 
phase of the response comprised next four minutes (Table 3). Introduction of the highest 
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dose of CCK-OP during phase 2b of the MMC over 30 s caused the sustained statistically 
signifi cant inhibitory effect lasting over the whole observation period. When the peptide 
was given over 60 and 120 s the effect was similar (Table 3). Thus the excitatory response 
was not observed after the highest CCK dose. 
The results obtained from the analysis of the jejunal recordings were roughly similar 
to those obtained from the duodenum and thus were not included here. 
Discussion
Injections of the various doses of CCK-OP elicited marked excitatory and inhibitory 
alterations in the myoelectric activity data derived from the ovine duodenum. As it has 
been quite well documented, CCK plays an important role in the control of small intestinal 
motility (OUYANG and COHEN, 1981). This may also be true in sheep (ONAGA et al., 
1997; ROMAŃSKI, 2004). In the present study, CCK-OP evoked shorter excitation and 
more pronounced inhibition of the spike bursts in the duodenum. Such a composed effect 
has already been previously reported. Biphasic and even triphasic responses of gastric 
and duodenal motility to CCK-OP and other peptides acting through CCK receptors has 
already been observed (COTTRELL and IGGO, 1984; GIULIANI et al., 1990; McLEAY and 
WONG, 1989). These fi ndings suggest that the mechanism of CCK action on duodenal 
motility is complex and may exhibit the adaptive features. Other reports indicate that the 
effect of CCK action on duodenal motility can be inhibitory or no effect can be observed 
while some authors observed simultaneous stimulatory in the jejunum (BUENO and 
PRADDAUDE, 1979; FLECKENSTEIN and ÖIGAARD, 1977; GIRALT and VERGARA, 2000; 
MARTINS et al., 2006). This warrants the speculation that the action of CCK on intestinal 
motility may depend also upon the intestinal segment and experimental conditions. 
The biphasic motor response to CCK observed here raises a question regarding the 
possible mechanism of dual CCK action on gastrointestinal motility. It is well known 
that the motor action of CCK is mediated by at least two peripheral subtypes of CCK 
receptors present in the gastrointestinal tract, including duodenal smooth muscles, enteric 
neurons, vagal afferent fi bers and the brain, and that CCK can exert its modulatory 
actions, including motility, within these structures (BEINFELD, 2001; MANTYH et al., 
1994; MIYASAKA and FUNAKOSHI, 2003; NOBLE et al., 1999). Therefore, the three most 
plausible mechanisms are presented below. One possibility is that CCK at the smaller 
doses stimulates a given CCK receptor subtype and in the higher dose further activates 
another CCK receptor subtype in the gut. If it is the case, the effect of CCK peptide can 
be due rather to the greater CCK1 receptor density in the duodenum than CCK2 receptor 
density than due to the greater affi nity of CCK1 receptors than of CCK2 receptors to CCK 
peptide (MIYASAKA and FUNAKOSHI, 2003; WANK, 1995). Thus, the primary stimulatory 
response can be followed by inhibition. It is well known that CCK is a gut hormone and 
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it is also a neuronal modulator (BEINFELD, 2001). Its action on intestinal motility can be 
either direct or can be mediated by several factors including the cholinergic system. This 
is probably also the case in sheep. Therefore, the second possibility is that the excitatory 
response to the direct action of CCK on smooth muscles can be followed by an inhibitory 
neuronal response. Since some gastrointestinal hormones can interact with CCK, the 
most convincing mechanism of the dual action of CCK on small intestinal motility (third 
possibility) is that the fi rst stimulatory response is elicited by the rapid action of CCK and 
the subsequent inhibitory action is induced by one of the inhibitory hormones including 
somatostatin that is released by CCK (MIYASAKA and FUNAKOSHI, 2003; ZAVROS and 
SHULKES, 1997). 
The smallest dose of CCK-OP induced weak effect in the duodenum although 
the discernible inhibitory changes preceded by short excitation were observed after 
moderate doses. As it was discussed earlier (ROMAŃSKI, 2007), the moderate doses 
of CCK-OP and even the highest doses administrated over 120 s might remain within 
the physiological range. Thus the only reasonably inference can be drawn from these 
fi ndings that endogenous CCK may also inhibit the myoelectric activity in the duodenal 
bulb and that the inhibitory effect of CCK represents the primary response in this region. 
In the duodenum, the small doses of CCK peptides elicited transient stimulation in the 
myoelectric and motor activities and the moderate doses evoked the dual effect. These 
observations may argue for the notion that also in the duodenum the action of CCK can 
be physiological and comprise both excitatory and inhibitory responses. 
The still unresolved question is whether CCK can be classifi ed as a stimulatory 
or an inhibitory hormone in respect to its actions on duodenal motility. The described 
retardation of duodenal phase 3 of the MMC by CCK, reversed by administration of the 
specifi c antagonist (ONAGA et al., 1997; THOR et al., 1990), can be considered as inhibitory 
action, while the induction of the fed pattern and stimulation of the duodenal spike bursts 
(ROMAŃSKI, 2004; THOR et al., 1990), also observed in the present study, can be interpreted 
as a stimulatory effect. The stimulatory effect of a moderate dose of CCK on duodenal 
motility seems to be primary (MIZUMOTO et al., 1992), and this conclusion can be inferred 
also from the present study. Since both stimulatory and inhibitory alterations in the 
duodenal myoelectric activity is accountable to CCK’s action, it is plausible to corroborate 
that CCK can either enhance or suppress the duodenal motility and its action can occur 
either in the interdigestive or digestive periods (ONAGA et al., 1997; ROMAŃSKI, 2007; 
THOR et al., 1990). Similarities between the effect of CCK peptide administration upon 
the duodenal and upper jejunal myoelectric activity suggests the functional continuity 
between these small-intestinal segments. These effects on the duodenal bulb MAI were 
more distinct but the duodenal bulb plays a reservuar role for the gastric content and the 
role of inhibitory mechanisms in the control of its motility seems to be greater. 
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Finally, the obtained results showed that the effect of CCK-OP was dependent upon 
the MMC phase. In the course of phase 1 of the cycle exhibiting no spike bursts, the 
effect of the hormone was stimulatory. During phase 2b of the MMC, when the duodenal 
myoelectric activity was intensive although irregular, the effect of CCK was inhibitory. 
This suggest that CCK controls the duodenal motility during various phases of the 
MMC cycle and is able to play its role depending on luminal stimuli in various motor 
conditions. Thus in sheep physiological doses of CCK peptides evoked vast effect on 
duodenal myoelectric activity, suggesting that in sheep, as in monogastric species, the 
role of CCK in the control of this function is remarkable. CCK might thus be considered 
as a physiological regulator of duodenal motility in sheep. 
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SAŽETAK
Kolecistokinin utječe na crijevni motilitet, ali još nije razjašnjen način njegova djelovanja. Cilj ovoga rada 
bio je istražiti učinke kolecistokinin-oktapeptida na mioelektričnu aktivnost dvanaesnika u normalno hranjenih 
neizgladnjivanih ovaca u tijeku dugotrajnoga pokusa. Bipolarna platinasta elektroda bila je u pet ovnova kirurški 
postavljena na stijenku duodenalne ampule, distalni dio duodenuma i jejunum. Instrument za mjerenje napona 
bio je postavljen blizu duodenalne elektrode da bi se provelo mioelektrično snimanje. U tijeku neprekidnoga 
mioelektričnoga snimanja bio je intravenski primijenjen 0,15 M NaCl ili kolecistokinin-oktapeptid. Polagano 
ubrizgavanje kolecistokinin-oktapeptida u dozi od 20 (tijekom 30 s), 200 (tijekom 30 ili 60 s) i 2000 (tijekom 
30, 60, ili 120 s) ng/kg tjelesne mase bilo je primijenjeno za vrijeme duodenalne faze 1, 2a, ili 2b migracijskoga 
motoričkoga kompleksa, tj. 5 minuta nakon pojave svake faze. Ubrizgavanje najmanje doze kolecistokinin-
oktapeptida dalo je slab, pretežito nesignifi kantan učinak na duodenalnu ampulu i na vrijednosti pokazatelja 
duodenalne mioelektrične aktivnosti. Učinci kolecistokinin-oktapeptida na mioelektričnu aktivnost duodenalne 
ampule bili su ovisni o dozi i usko povezani s fazom migrirajućega motornoga kompleksa. Veće doze hormona u 
dvanaesniku imale su kratak stimulacijski s prijelazom na dugi inhibicijski bifazni učinak na indeks mioelektrične 
aktivnosti. Ovi učinci bili su obratno razmjerni s trajanjem ubrizgavanja hormona. Primjena hormona u većim 
dozama uzrokovala je manje izražen bifazični učinak. Može se zaključiti da kolecistokinin ima stimulacijski i 
inhibicijski (bifazični) fi ziološki učinak na motilitet dvanaesnika u neizgladnjivanih ovaca.
Ključne riječi: ovca, duodenalna ampula, dvanaesnik, mioelektrična i motorička aktivnost, kolecistokinin-
oktapeptid, migrirajući mioelektrični kompleks 
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